Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05071963 · ClinicalTrials.gov registry record

INSPIRE Pipeline™ Shield Post Approval Study

A clinical trial of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.

Active
Registry status
246
Enrollment target
16
Study locations

NCT05071963 is a study of Intracranial Aneurysm that is active but no longer recruiting, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 246 participants, below the 9,179-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 16 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05071963, a study of Intracranial Aneurysm, is active but no longer recruiting, sponsored by Medtronic Neurovascular Clinical Affairs.

ACTIVE NOT RECRUITING
Registry status
246 participants
Enrollment target
16
Study locations

Study Summary

The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.

Conditions Studied

Intracranial Aneurysm

Interventions

  • DEVICE Treatment of Intracranial Aneurysms

Study Locations (16)

New York

  • NYU Langone Medical Center - New York
  • Montefiore Medical Center - New York

Pennsylvania

  • Geisinger Medical Center - Danville
  • Hospital of the University of Pennsylvania - Philadelphia

Alabama

  • University of Alabama at Birmingham - Birmingham

Connecticut

  • Yale New Haven Hospital - New Haven

Florida

  • Baptist Medical Center Jacksonville - Jacksonville

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Endeavor Health - Evanston Hospital - Evanston

Kentucky

  • Norton Healthcare - Louisville

Trial Details

FieldValue
Enrollment Target 246 participants
Start Date 2021-12-20
Est. Completion 2028-04

Sponsor

Medtronic Neurovascular Clinical Affairs

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05071963

The ClinicalTrials.gov registry entry for NCT05071963 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,179-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Treatment of Intracranial Aneurysms is the first listed.

NCT05071963 reports 16 study locations spanning 14 distinct geographic areas - top geographies include New York, Pennsylvania, Alabama.

Frequently Asked Questions

What is clinical trial NCT05071963 about?

NCT05071963 is a clinical study titled "INSPIRE Pipeline™ Shield Post Approval Study". The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pip...

What is the current status of trial NCT05071963?

This trial is currently active not recruiting. The enrollment target is 246 participants. The study started on 2021-12-20. Estimated completion is 2028-04.

What conditions does trial NCT05071963 study?

This clinical trial studies the following conditions: Intracranial Aneurysm.

What interventions are being tested in trial NCT05071963?

The interventions under investigation include: Treatment of Intracranial Aneurysms (DEVICE).

Who is sponsoring clinical trial NCT05071963?

This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05071963 being conducted?

This trial has 16 study locations across Alabama, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intracranial Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Intracranial Aneurysm

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.